Search Results - "Alshemmari, Salem H"

Refine Results
  1. 1

    Prognostic impact of chronic lymphocytic leukemia comorbidity index in a young population: a real-world evidence study of a national gulf region cohort by Alshemmari, Salem H, AlSarraf, Ahmad, Kaempf, Andy, Danilov, Alexey V

    Published in BMC cancer (13-05-2024)
    “…In chronic lymphocytic leukaemia (CLL), comorbidities assessed by the CLL comorbidity index (CLL-CI) have been associated with outcomes in Western cohorts. We…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Chronic lymphocytic leukemia in a young population by Alshemmari, Salem H., Hamdah, Abdulaziz, Pandita, Ramesh, Kunhikrishnan, Anita

    Published in Leukemia research (01-11-2021)
    “…•The incidence of CLL in Kuwait is rare, with an annual incidence is 0.4 per 100,000.•There are some biological differences in CLL to what has been published,…”
    Get full text
    Journal Article
  4. 4

    UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring by Matar, Kamal M., Alshemmari, Salem H., Refaat, Samar, Anwar, Alia

    Published in Scientific reports (02-06-2020)
    “…Busulfan (Bu) is an alkylating agent commonly used in preparative regimens for hematologic malignant and non-malignant patients undergoing hematopoietic stem…”
    Get full text
    Journal Article
  5. 5

    Evaluation of the CLL-IPI and IPS-E Prognostic Indices in a Young Middle Eastern Population with Chronic Lymphocytic Leukemia: A Retrospective Analysis at the Kuwait Cancer Control Center by Alshemmari, Salem H., Alsarraf, Ahmad, Kunhikrishnan, Anita, Pandita, Ramesh

    Published in Medical principles and practice (01-10-2023)
    “…Introduction: The Chronic Lymphocytic Leukemia International Prognostic Index (CLL-IPI) is a powerful prognostic tool validated in multiple Western…”
    Get full text
    Journal Article
  6. 6

    Prognosis and Outcome of Fit Patients with Acute Myeloid Leukemia in Kuwait by Alshemmari, Salem H., Pandita, Ramesh, Ram, Mohan, Rajan, Reshmi, Aouda, Kloud, Samuel, Lovely

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)
    “…Acute myeloid leukemia (AML) data from the Middle East are limited to single-center studies. We report leukemia-free survival (LFS) and overall survival (OS)…”
    Get full text
    Journal Article
  7. 7

    Analysis of Common Driver Mutations in Philadelphia-Negative Myeloproliferative Neoplasms by Alshemmari, Salem H., Rajan, Reshmi, Ameen, Reem, Almazyad, Mazyad

    Published in Clinical lymphoma, myeloma and leukemia (01-07-2021)
    “…Philadelphia-negative myeloproliferative neoplasms (MPNs) are a group of hematopoietic stem cell disorders that include polycythemia vera (PV), essential…”
    Get full text
    Journal Article
  8. 8

    Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region by Alshemmari, Salem H, Siddiqui, Mustaqeem A, Pandita, Ramesh, Osman, Hani Y, Cherif, Honar, O'Brien, Susan, Marashi, Mahmoud, Al Farsi, Khalil

    Published in Acta haematologica (2024)
    “…Despite recent advances in diagnosis, prognostication, and treatment options, chronic lymphocytic leukemia (CLL) is still a largely incurable disease. New…”
    Get more information
    Journal Article
  9. 9

    Epidemiology of de novo Acute Myeloid Leukemia in Kuwait per the 2016 WHO Classification by Alshemmari, Salem H., Almazyad, Mazyad, Ram, Mohan, John, Liby Mariamma, Alhuraiji, Ahmed

    Published in Medical principles and practice (01-07-2022)
    “…Objective: Acute myeloid leukemia (AML) is a hematological malignancy that arises from the clonal proliferation of immature myeloid cells. Although the number…”
    Get full text
    Journal Article
  10. 10

    Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review by Alshemmari, Salem H., Rajan, Reshmi, Emadi, Ashkan

    Published in Medical principles and practice (01-01-2016)
    “…Primary myelofibrosis (PMF) is a rare chronic BCR-ABL1-negative myeloproliferative neoplasm characterized by progressive bone marrow fibrosis, inefficient…”
    Get full text
    Journal Article
  11. 11

    Association analysis of genetic variants in the ghrelin and tumor necrosis factor α genes and the risk for non-Hodgkin's lymphoma in Kuwaitis by Alrashid, Maryam H, Al-Serri, Ahmad, Alshemmari, Salem H, Geo, Jeethu Anu, Al-Bustan, Suzanne A

    “…Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy in the world. Many etiologic factors have been implicated in the risk of developing…”
    Get more information
    Journal Article
  12. 12

    JAK2V617F allele burden in patients with myeloproliferative neoplasms by Alshemmari, Salem H., Rajaan, Reshmi, Ameen, Reem, Al-Drees, Mohammad A., Almosailleakh, Marwa R.

    Published in Annals of hematology (01-05-2014)
    “…Myeloproliferative neoplasms (MPNs) are clonal malignant diseases that represent a group of conditions including polycythemia vera (PV), essential…”
    Get full text
    Journal Article
  13. 13

    Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals by Alrashid, Maryam H., Al-Serri, Ahmad, Alshemmari, Salem H., Koshi, Philip, Al-Bustan, Suzanne A.

    Published in Molecular diagnosis & therapy (01-04-2016)
    “…Background and Objective Warfarin is the most widely prescribed oral anticoagulant worldwide. The narrow therapeutic index and the large variation in the…”
    Get full text
    Journal Article
  14. 14

    The place of death of patients with cancer in Kuwait by Alshemmari, Salem H, Elbasmi, Amani A, Alsirafy, Samy A

    Published in BMJ supportive & palliative care (01-12-2015)
    “…The place of death (PoD) has a significant effect on end-of-life care for patients dying of cancer. Little is known about the place of cancer deaths in our…”
    Get more information
    Journal Article
  15. 15

    Genotypic and Phenotypic Differences between Nodal and Extranodal Diffuse Large B-Cell Lymphomas by Al-Humood, Salah A., Al-Qallaf, Aisha S., AlShemmari, Salem H., Francis, Issam M., Junaid, Thamradeen A., Marouf, Rajaa A., Al-Mulla, Fahd

    “…Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of diseases that have diverse clinical, pathological, and biological features. Here, it is shown…”
    Get full text
    Journal Article
  16. 16

    Extranodal lymphoma: a comparative study by AlShemmari, Salem H, Ameen, Reem M, Sajnani, Kamlesh P

    Published in Hematology (Luxembourg) (01-06-2008)
    “…The incidence of extranodal non-Hodgkin's lymphoma (NHL) is increasing worldwide. The epidemiology of NHL in the Middle East is largely unknown. We evaluated…”
    Get more information
    Journal Article
  17. 17

    Representation of Expatriates Among Cancer Patients in Kuwait and the Need for Culturally-Competent Care by Alshemmari, Salem H., Refaat, Samar M., Elbasmi, Amani A., Alsirafy, Samy A.

    Published in Journal of psychosocial oncology (01-05-2012)
    “…From 2000 to 2007, 11,793 cancer patients received treatment in Kuwait. Non-Kuwaitis accounted for 6,016 (51%) patients. They came from 68 countries, mainly…”
    Get full text
    Journal Article
  18. 18

    Performance status and deaths among children registered in Kuwait National Primary ImmunoDeficiency Disorders Registry by Al-Herz, Waleed, Zainal, Mohammad E, Alenezi, Hamid M, Husain, Khalid, Alshemmari, Salem H

    “…Children with primary immunodeficiency disorders (PIDD) have an increased risk of suffering from physical, social, and psychological problems. The aim of this…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Factors Associated with Successful Mobilization of Progenitor Hematopoietic Stem Cells Among Patients with Lymphoid Malignancies by Ameen, Reem M., Alshemmari, Salem H., Alqallaf, Dana

    Published in Clinical lymphoma & myeloma (01-04-2008)
    “…This study's main aim was to assess the effect of 2 mobilization regimens (granulocyte colony-stimulating factor [G-CSF] and chemotherapy vs. G-CSF alone) on…”
    Get full text
    Journal Article